Premium
P4‐311: IS FLORBETAPIR‐PET OCCIPITAL SUVR A LATE BIOMARKER IN MILD OR MODERATE AD DEMENTIA AS COMPARED TO HIPPOCAMPAL VOLUME?
Author(s) -
Witte Michael,
Yu Peng,
Wang Shufang,
Castelluccio Peter,
Hochstetler Helen,
Joshi Abhinay,
Dell'Agnello Grazia,
Henley David,
Degenhardt Elisabeth,
Walker Sara Kollack,
Devous Michael D.,
Devous Adam,
Trzepacz Paula
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.07.082
Subject(s) - precuneus , neuroimaging , hippocampus , posterior cingulate , medicine , psychology , hippocampal formation , neuroscience , nuclear medicine , cardiology , cognition
P4-311 IS FLORBETAPIR-PET OCCIPITAL SUVR A LATE BIOMARKER IN MILD OR MODERATE AD DEMENTIA AS COMPARED TO HIPPOCAMPAL VOLUME? Michael Witte, Peng Yu, Shufang Wang, Peter Castelluccio, Helen Hochstetler, Abhinay Joshi, Grazia Dell’Agnello, David Henley, Elisabeth Degenhardt, Sara Kollack Walker, Michael D. Devous, Sr,, Adam Devous, Sr., Paula Trzepacz, Eli Lilly and Company, Indianapolis, Indiana, United States; Eli Lilly and Company, Indianapolis, Indiana, United States; Bucher & Christian Consulting, Inc., Philadelphia, Pennsylvania, United States; Avid Radiopharmaceuticals, Philadelphia, Pennsylvania, United States; Eli Lilly Italia, Sesto Fiorentino, Italy; Eli Lilly and Company, Indianapolis, Indiana, United States; Avid Radiopharmaceuticals, Inc., Philadelphia, Pennsylvania, United States. Contact e-mail: witte_michael_m@lilly.com